The Decent Value screen is built on a simple premise: a stock should be cheap enough to appeal to value investors, but not so cheap that it loses the fundamental support that protects against value traps. ENVISTA HOLDINGS CORP (NYSE:NVST) qualifies under this methodology, with a valuation score that stands out while profitability, health, and growth remain at acceptable levels.
What the Decent Value Screen Requires
The screen selects stocks with a strong valuation score while still maintaining decent profitability, health, and growth. This is a deliberate departure from deep value methods that hunt for the lowest multiples without checking whether the underlying business is stable. By filtering on all four dimensions, the screen aims to separate stocks that are merely cheap from those that are genuinely undervalued.
Envista's Valuation Is the Standout
Envista's fundamental report assigns it a valuation score of 7 out of 10, the strongest of the four main components. That score is supported by a set of multiples that look particularly cheap next to the broader Health Care Equipment & Supplies industry.
- Price/Earnings ratio of 18.60, versus an industry average of 56.04
- Price/Forward Earnings of 17.05, versus an industry forward average above 100
- Enterprise Value to EBITDA ratio cheaper than 90.37% of industry peers
- Price/Free Cash Flow ratio cheaper than 91.44% of industry peers
The absolute P/E ratio is not exceptionally low, but it is also well below the S&P 500's current P/E of 26.12 and its forward P/E of 21.68. That combination of a reasonable nominal multiple and a large discount to both the sector and the broad market is a familiar value investing setup.
Investors who want to see the full details behind this assessment can consult the fundamental analysis report for the complete breakdown.
Profitability Is Decent, Not Spectacular
The profitability score of 6 out of 10 is acceptable for a value-oriented strategy, though it does not signal a market leader. The key figures show a business that is generating solid margins relative to its industry.
- Operating margin of 10.62%, outperforming 80.75% of industry peers
- Gross margin of 55.86%, roughly in line with the industry
- Profit margin of 3.33%, above 74.87% of peers
- Return on Invested Capital of 5.00%, above 77.54% of peers
One caveat is that the three-year average ROIC of 3.73% remains below the industry average of 9.06%, and the report notes that ROIC is currently below the cost of capital. That suggests the company is still in the process of improving its capital efficiency, which adds an element of execution risk to the value case.
Health: Balance Sheet Looks Manageable
Financial health is also scored 6 out of 10. The balance sheet appears stable enough to support the company while it works through this transition.
- Current ratio of 2.43, indicating no problem covering short-term obligations
- Quick ratio of 2.07, confirming a comfortable liquidity position
- Debt-to-equity ratio of 0.47, suggesting limited reliance on debt financing
- Altman-Z score of 1.91, placing the company in the grey zone but in line with the industry
The debt to free cash flow ratio of 5.79 is a neutral figure; it would take roughly 5.8 years of free cash flow to pay off total debt. That is not alarming for a company of this scale.
Growth Is the Potential Catalyst
A stock becomes more interesting for value investors when the market is not giving it credit for future growth. Envista's growth score is 6 out of 10, but the underlying figures point to an acceleration.
- EPS grew 70.93% in the last year
- Revenue grew 11.89% in the last year
- EPS is expected to grow at an average annual rate of 22.46% over the next years
- Revenue is expected to grow at 7.58% per year
The report also notes that the EPS growth rate is accelerating when comparing historical performance to forward estimates. A cheap valuation combined with improving growth expectations is exactly the kind of combination the Decent Value screen is designed to catch.
Risks to Keep in Mind
The most obvious limitation is the dividend score of 0; Envista does not pay a dividend, so income-focused investors will not find support here. The Altman-Z score and the gap between ROIC and WACC are also worth monitoring. If the company fails to deliver on its growth forecasts, the stock could stay cheap for a long time, which is the classic risk for any value strategy.
What Other Screens Confirm
NVST also appears on two other screens that reinforce the Decent Value case. The free cash flow screen confirms that the cheap valuation is backed by real cash generation, with the stock producing strong free cash flow relative to its market price. Meanwhile, the high EPS growth screen adds a growth angle, noting that NVST is profitable, financially healthy, and showing strong recent earnings growth. Together, these screens support the idea that the stock is not just inexpensive, but also fundamentally supported.
Investors who want to explore other stocks that combine a strong valuation with decent fundamentals can run the same methodology through the Decent Value screen to see the full list of candidates.
Disclaimer: This article is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Always conduct your own research and consider your risk tolerance before making investment decisions.
Read full article here »
View the Zacks #1 Rank List
Envista Holdings (NYSE:NVST): A Decent Value Play with Undervaluation and Growth Potential
The Decent Value screen is built on a simple premise: a stock should be cheap enough to appeal to value investors, but not so cheap that it loses the fundamental support that protects against value traps. ENVISTA HOLDINGS CORP (NYSE:NVST) qualifies under this methodology, with a valuation score that stands out while profitability, health, and growth remain at acceptable levels.
What the Decent Value Screen Requires
The screen selects stocks with a strong valuation score while still maintaining decent profitability, health, and growth. This is a deliberate departure from deep value methods that hunt for the lowest multiples without checking whether the underlying business is stable. By filtering on all four dimensions, the screen aims to separate stocks that are merely cheap from those that are genuinely undervalued.
Envista's Valuation Is the Standout
Envista's fundamental report assigns it a valuation score of 7 out of 10, the strongest of the four main components. That score is supported by a set of multiples that look particularly cheap next to the broader Health Care Equipment & Supplies industry.
The absolute P/E ratio is not exceptionally low, but it is also well below the S&P 500's current P/E of 26.12 and its forward P/E of 21.68. That combination of a reasonable nominal multiple and a large discount to both the sector and the broad market is a familiar value investing setup.
Investors who want to see the full details behind this assessment can consult the fundamental analysis report for the complete breakdown.
Profitability Is Decent, Not Spectacular
The profitability score of 6 out of 10 is acceptable for a value-oriented strategy, though it does not signal a market leader. The key figures show a business that is generating solid margins relative to its industry.
One caveat is that the three-year average ROIC of 3.73% remains below the industry average of 9.06%, and the report notes that ROIC is currently below the cost of capital. That suggests the company is still in the process of improving its capital efficiency, which adds an element of execution risk to the value case.
Health: Balance Sheet Looks Manageable
Financial health is also scored 6 out of 10. The balance sheet appears stable enough to support the company while it works through this transition.
The debt to free cash flow ratio of 5.79 is a neutral figure; it would take roughly 5.8 years of free cash flow to pay off total debt. That is not alarming for a company of this scale.
Growth Is the Potential Catalyst
A stock becomes more interesting for value investors when the market is not giving it credit for future growth. Envista's growth score is 6 out of 10, but the underlying figures point to an acceleration.
The report also notes that the EPS growth rate is accelerating when comparing historical performance to forward estimates. A cheap valuation combined with improving growth expectations is exactly the kind of combination the Decent Value screen is designed to catch.
Risks to Keep in Mind
The most obvious limitation is the dividend score of 0; Envista does not pay a dividend, so income-focused investors will not find support here. The Altman-Z score and the gap between ROIC and WACC are also worth monitoring. If the company fails to deliver on its growth forecasts, the stock could stay cheap for a long time, which is the classic risk for any value strategy.
What Other Screens Confirm
NVST also appears on two other screens that reinforce the Decent Value case. The free cash flow screen confirms that the cheap valuation is backed by real cash generation, with the stock producing strong free cash flow relative to its market price. Meanwhile, the high EPS growth screen adds a growth angle, noting that NVST is profitable, financially healthy, and showing strong recent earnings growth. Together, these screens support the idea that the stock is not just inexpensive, but also fundamentally supported.
Investors who want to explore other stocks that combine a strong valuation with decent fundamentals can run the same methodology through the Decent Value screen to see the full list of candidates.
Disclaimer: This article is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Always conduct your own research and consider your risk tolerance before making investment decisions.
Read full article here »